Nephron Research LLC
Episodes
79 episodes
Nephron Research: Latest on the PFA Revolution - KOL Takeaways from HRS
This year’s Heart Rhythm Society (HRS) meeting was a great opportunity to take the pulse of electrophysiologists on how they’re incorporating Farapulse and Medtronic’s PulseSelect into their practices, whether these catheters are living u...
China Tools & Dx Market Update KOL Call - 5/17/24
The China market remains dynamic for our Life Science Tools & Diagnostics coverage. On May 17th, Jack Meehan hosted a discussion with Dr. Mao Mao for an updated on-the-ground view as to the factors driving investment trends in the reg...
Nephron Research: China KOL Call - 2/2
On Dec. 11th, Jack Meehan hosted a KOL discussion for an updated on-the-ground view as to the factors driving investment trends in Life Science Tools & Diagnostics in the region. Topics of discussion included: 1) Perspectives on the current...
Nephron Research: China KOL Call - 1/2
On Dec. 11th, Jack Meehan hosted a KOL discussion for an updated on-the-ground view as to the factors driving investment trends in Life Science Tools & Diagnostics in the region. Topics of discussion included: 1) Perspectives on the current...
Nephron Bioprocessing Industry KOL Call - 12/5/23
On Dec. 5th, Jack Meehan hosted a KOL call on the bioprocessing industry. Bioprocessing has historically been one of the fastest growing areas of our coverage, and we think the long-term outlook is bright. However, the industry is facing ...
China Tools & Dx Market Update KOL Call - 9/8/23
Our Tools & Dx coverage is facing a macro and micro storm in the China market. Jack Meehan hosted a discussion with Dr. Mao Mao and Dr. John Zhang for an on-the-ground view as to the factors driving investment trends in Life Scienc...
Nephron Research: KOL Call on Lab/Dx Industry Updates
On June 27th, Jack Meehan hosted a discussion on the laboratory and diagnostic industries with two thought leaders in the space. Topics of discussion included:COVID-19: Demand for COVID-19 testing solutions is winding ...
Bioprocessing Industry KOL Call
On June 6th, Jack Meehan hosted a KOL call on the bioprocessing industry. Topics of discussion on this conference call included an overview on the environment for bioprocessing purchasing, stocking trends, demand dynamics from COVID-19...
Nephron FDA KOL Call on CRC Liquid Biopsy Tests
Following the read-out of Guardant Health’s ECLIPSE study, the big debate is on FDA approvability of the Shield assay in CRC screening. On April 12th, Jack Meehan hosted two former FDA leaders to discuss Shield’s clinical data in ECLIPSE, FD...
CRC Screening KOL Call Post-ECLIPSE for EXAS/GH
Following the read-out of Guardant Health’s ECLIPSE study, we hosted a KOL discussion on how the results and potential introduction of liquid biopsy might influence the market for CRC screening. We were joined by one primary care physici...
Nephron Research: Bioprocessing Industry KOL Call
Joseph Tyler, MS, Consultant at Pharmsupply Inc.Brian Tham, Biotechnology Consultant at Pelegrine Bio.On November 22nd, Nephron hosted a KOL call on the bioprocessing industry. Bioprocessing has historically been one of the fa...
KOL Views on CRC Screening - 10/5/22
On October 5th, we hosted an expert call discussion on how the ECLIPSE results and potential introduction of liquid biopsy might influence the market for CRC screening. Topics of discussion included adoption of non-invasive diagnostics f...
KOL Call on NGS Innovation & Genomics
On September 8th, we hosted a KOL call with two researchers to discuss their experience with Illumina and considerations when evaluating competitor systems. Dr. Joseph Powell is a current NovaSeq customer, who weighed in on purchasing perspecti...
Nephron Research: Myriad Genetics (MYGN) PRIME Care Study KOL Call w/ Dr. Charlie Nemeroff
Myriad published the results of the PRIME Care Study on Tuesday afternoon in JAMA. In the 2K patient study, GeneSight was successful on both of the co-primary...
China Diagnostics & Market Update KOL Call
On Friday we were joined for a discussion with two diagnostics experts, Ms. Camille Hu and Terry Robins, who provided an on-the-ground view as to what is happening in the China market for diagnostics testing. Topics of discussion include...
KOL Views on Biopharma Services for CROs & Tools
On March 29th, Richard Panico and John Diaz joined us for an update on the latest trends in biopharma services. The durability of biopharma investment has been a major area of focus for our CROs and life science tools coverage to st...
KOL Views on CRC Diagnostics for Cologuard & Liquid Biopsy Post ASCO-GI
Following the ASCO-GI annual meeting, Nephron hosted a discussion with two key opinion leaders to discuss the latest innovation in diagnostics for colorectal cancer (CRC). Topics of discussion included adoption of non-invasive diagnostic...
China Dx Purchasing Expert Update - Mon, 11/1
Heading into 3Q21 earnings, one of the top debates for our coverage is the China region – and changes in policy which may encourage “buy local” initiatives in Diagnostics. Diagnostics experts Dr. Mao Mao and Ms. Camille Hu jo...
Nephron Research Industry Expert Series: NGS & Genomics Tech Assessment with Dr. Albert Vilella
This morning, Nephron hosted Dr. Albert Vilella for a conversation focused on next generation sequencing (NGS) and genomics technologies. Topics of discussion included investment trends in NGS, an overview on the differentiation amongst n...
340B at a Tipping Point: Legal, Regulatory & Legislative Perspectives
On Monday July 12th, Nephron hosted Ross Margulies of Foley Hoag. Topics of discussion included:The status of 340B under the Biden administration, including the threat to fine drug makers for curtailing distribution of disco...
Nephron Biopharma End Market Review
On Friday May 21st at 10:30 AM ET, Jack Meehan, lead analyst Life Science Tools & Diagnostics, and Eric Percher, lead analyst Pharma Supply Chain, Pricing & Policy, hosted a joint 20-min call exploring their recent reports on biopharma ...
Nephron Expert Series: Bioprocessing Expert Howard Levine - May 18th
On May 18th, Nephron Research hosted a discussion on the latest updates in bioprocessing with one of the top thought leaders in the industry, Dr. Howard Levine. Topics of discussion included the backdrop for industry funding, an a...
Nephron Expert Series: Dr. Joel Brill - Early Cancer Detection LBx Payor Discussion
On Friday March 12th, Nephron hosted one of the top diagnostics payor experts in the field, Dr. Joel Brill for a discussion on reimbursement prospects for early cancer detection testing. Our discussion focused on the health economic...